EU

June 20, 2025
Blog
No Comments

No Patent For Intermediates without Efficacy

Introduction On May 27, 2025, in Zeria Pharmaceutical Co. Ltd. v. Deputy Controller of Patents and Designs1, the Delhi High Court upheld the refusal of divisional patent, affirming that minor structural modifications of known pharmaceutical compounds—especially intermediates—must still demonstrate enhanced therapeutic efficacy to be patentable under Section 3(d) of the Indian Patents Act, 1970. The […]

March 19, 2025
Blog
No Comments

Concept of Intermediary Liability in Trademark Infringement

Introduction The case of Lifestyle Equities CV & Anr. v. Amazon Technologies, Inc. & Ors1.represents a significant milestone in Indian trademark law, particularly concerningintermediary liability in the digital age. The dispute arose when Lifestyle Equities CV,owner of the “Beverly Hills Polo Club” (BHPC) mark, alleged that Amazon facilitated thesale of products bearing a deceptively similar […]

March 5, 2025
Blog
No Comments

13 Years in the Making: The Philips Judgment and its Impact on SEP Litigation in India

Introduction The Delhi High Court (DHC)’s recent decision in Koninklijke Philips Electronics N.V. vs. Maj (Retd) Sukesh Behl & Anr. [1] 1is another firm reinforcement of India’s growing reputation as a key jurisdiction for Standard Essential Patent (SEP) enforcement. While India has consistently handled SEP litigation with legal sophistication and commercial pragmatism, this ruling reinforces […]